Heart Failure
-
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
Load moreHeart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.
Load Less
Videos
-
20 September 2019
-
18 September 2019
-
13 September 2019
-
12 September 2019
-
12 September 2019
-
11 September 2019
Pages
-
Andrew JS Coats, Giuseppe RosanoCardiac Failure Review 2019;5(3):128–9.DOI: https://doi.org/10.15420/cfr.2019.5.3.FO1
-
Deepak Bhatt, Anna Meta Dyrvig Kristensen, Manan Pareek, et alUS Cardiology Review 2019;13(2):83–7.DOI: https://doi.org/10.15420/usc.2019.13.2
-
Nicole Ebner, Stephan Von HaehlingCardiac Failure Review 2019;5(3):173–5.DOI: https://doi.org/10.15420/cfr.2019.9.2
-
Erik H Van ItersonCardiac Failure Review 2019;5(3):162–8.DOI: https://doi.org/10.15420/cfr.2019.10.2
